Quick Takeaways
- Christy J. Oliger has 8 issuer positions tracked on this page.
- Estimated disclosed ownership value: $425,399.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Christy J. Oliger
- Location
- Newton, MA
- Summary
- The estimated net worth of Christy J. Oliger is at least $425,399 dollars as of 07 Apr 2026. Christy J. Oliger is the Director of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) stock worth about $296.9K. Christy J. Oliger is the Director of Vera Therapeutics, Inc. and owns shares of Vera Therapeutics, Inc. (VERA) stock worth about $128.5K.
- Signature
- /s/ Shawn Glidden, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Christy J. Oliger and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Nuvalent, Inc. ($296,871).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Christy J. Oliger
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NUVL | Nuvalent, Inc. | Director | $296,871 | 18 Jun 2025 | ||
| VERA | Vera Therapeutics, Inc. | Director | $128,528 | 14 May 2025 | ||
| KPTI | Karyopharm Therapeutics Inc. | Director | 28 May 2025 | |||
| LVTX | LAVA Therapeutics NV | Director | 13 Nov 2025 | |||
| RYZB | RayzeBio, Inc. | Director | 26 Feb 2024 | |||
| RETA | REATA PHARMACEUTICALS INC | Director | 26 Sep 2023 | |||
| REPL | Replimune Group, Inc. | Director | 01 Apr 2026 | |||
| SRRA | Sierra Oncology, Inc. | Director | 01 Jul 2022 |
Insider Transactions Reported by Christy J. Oliger:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.